Bioactive Potential, Essential Oil Analysis of Inula Cappa Collected from Uttarakhand Himalaya, India

Authors

Sandhya Dogra

Professor, Department of Microbiology, Sai Institute of Paramedical and Allied Sciences, Dehradun, Uttarakhand (India)

Sarla Saklani

Professor, Department of Pharmaceutical Chemistry, HNBGU, Srinagar, Uttarakhand (India)

Article Information

DOI: 10.51584/IJRIAS.2026.11010027

Subject Category: Social science

Volume/Issue: 11/1 | Page No: 333-339

Publication Timeline

Submitted: 2026-01-03

Accepted: 2026-01-15

Published: 2026-01-28

Abstract

Inula cappa (Buch.-Ham. ex D. Don) DC. (Asteraceae), a high potential medicinal herb and traditionally used in Ayurvedic, Chinese and Tibetan medicine, has been recognized for its diverse pharmacological properties. The present study aimed to evaluate the antioxidant potential and antimicrobial effect of leaf extracts obtained using different solvents. Antioxidant activity was assessed through standard assays, including DPPH radical scavenging, revealing a concentration-dependent free radical scavenging effect. The methanolic extract exhibited the highest antioxidant potential, correlating positively with its total phenolic and flavonoid content. Bioactive compounds were identified by GCMS. Antimicrobial activity was tested minimum inhibitory concentration (MIC) methods. Results demonstrated notable inhibition zones, particularly against Staphylococcus aureus and Escherichia coli, with the methanolic extracts showing superior efficacy compared to other extracts. These findings suggest that Inula cappa leaves are a promising source of natural antioxidants and antimicrobial agents, supporting their potential application in pharmaceutical formulations.

Keywords

Inula cappa; antioxidant capacity; antimicrobial effects; leaves extracts, Uttarakhand Himalaya

Downloads

References

1. Bao H. S., Hou J. Y., Hu H. J., Li Y. T., Zheng L., Huang Y., et al. (2019). Determination of plasma protein binding rate of nine compounds Inula cappa extraction based on method of equilibrium dialysis. China. J. Chin. Mat. Med. 44. [Google Scholar] [Crossref]

2. Bissery M. C., Vrignaud P., Lavelle F., Chabot G. G. (1996). Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice. Anticancer. Drugs 7 (4), 437–460. [Google Scholar] [Crossref]

3. Chang L. L., Qi W. J. (2020). Research progress of Chinese medicine monomer to improve endothelial cell permeability. Beijing Tradit. Chin. Med. 39 (12), 1331–1334. Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of the people’s Republic of China, Part 1. Beijing: China Medical Science Press, 1715. [Google Scholar] [Crossref]

4. Dong M., Hiwasa T., Cong B. (2015). Protein kinase Cα-mediated cytotoxic activity of ineupatorolide B from Inula cappa DC HeLa cells. Int. J. Oncol. 47 (5), 1839–1844. [Google Scholar] [Crossref]

5. Feng X. Y., Liu C. D., Zhang Y. M., Kang Z., Jiang Z. T., Yu H. (2019). Determination of plasma protein binding rate of gardenia glycosides, peony glycosides and naringin in gastritis ling granules by equilibrium dialysis. Int. J. Traditional Chin. Med. 41 (06), 608–613. [Google Scholar] [Crossref]

6. Gao L. C., Zhang W., Fan L., Zhou H. H. (2011). Inflammation affects the expression and activity of drug transporters. Chin. Pharmacol. Bul. 27 (01), [Google Scholar] [Crossref]

7. Gong Z. P., Chen T. T., Hou J. Y., Wu L. L., Li M., Li Y. T., et al. (2017a). Analysis of components in plasma from effective fractions of Inula cappa based on UHPLC/Q-TOF/MS. Chin. Pharmacol. Bul. 33 (11), 1605–1610. [Google Scholar] [Crossref]

8. Gong, Z., Chen, Y., Zhang, R., Wang, Y., Guo, Y., Yang, Q., ... & Zhu, X. (2014). Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats. International journal of molecular sciences, 15(1), 456-467. [Google Scholar] [Crossref]

9. Gong, Z. P., Hou, J. Y., Li, M., Wu, L. L., Chen, T. T., Li, Y. J., ... & Wang, Y. L. (2017). Metabolism of Inula cappa extract by rat intestinal bacteria in vitro. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China journal of Chinese materia medica, 42(18), 3584-3590. [Google Scholar] [Crossref]

10. Gong Z. P., Xiong D. F. F., Li M., Wu L. L., Chen T. T., Li Y. T., et al. (2017c). Analysis of chemical constituents of effective components of Inula cappa. J. Anhui. Agri.Sci. 45 (29), 131–133. [Google Scholar] [Crossref]

11. Guan H. Y., Lan Y. Y., Liao S. G., Liu J. H., Han Y., Zheng L., et al. (2014). Caffeoylquinic acid derivatives in. Inula cappa Nat. Prod. Res. Dev. 26 (12), 1948–1952. [Google Scholar] [Crossref]

12. Guangxi Zhuang Autonomous Region, Department of Health (1992). in Guangxi herbal medicine standard (Nanning: Guangxi Science and Technology Press; ), 49. [Google Scholar] [Crossref]

13. Guizhou Province Drug Administration (2003). Quality standards for Chinese herbal medicines and ethnic medicines in Guizhou Province. Beijing: China Medical Science and Technology Press, 176. [Google Scholar] [Crossref]

14. Hu L., He Z. S. (2012). Advances in chemical composition and pharmacological activity of Inula cappa . Chin. J. Mod. Appl. Pharm. 29 (10), 889–894. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles